Vertex Pharmaceuticals Inc / Ma

CHARLES SCHWAB INVESTMENT MANAGEMENT INC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,859,221

Value ($000)

842,896

Weight

0.1%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	842,896	0.1%	1,859,221	12/31/2025
2025 Q3	11/10/2025	716,674	0.1%	1,829,931	9/30/2025
2025 Q2	8/12/2025	789,618	0.1%	1,773,625	6/30/2025
2025 Q1	9/15/2025	836,451	0.2%	1,725,281	3/31/2025
2024 Q4	2/6/2025	670,032	0.1%	1,663,849	12/31/2024
2024 Q3	11/12/2024	756,381	0.1%	1,626,347	9/30/2024
2024 Q2	8/12/2024	752,758	0.1%	1,605,986	6/30/2024
2024 Q1	5/9/2024	650,679	0.2%	1,556,612	3/31/2024
2023 Q4	2/6/2024	614,081	0.2%	1,509,206	12/31/2023
2023 Q3	11/8/2023	510,283	0.1%	1,467,428	9/30/2023
2023 Q2	8/10/2023	510,222	0.1%	1,449,864	6/30/2023
2023 Q1	5/12/2023	454,689	0.1%	1,443,137	3/31/2023
2022 Q4	2/13/2023	408,921	0.1%	1,416,028	12/31/2022
2022 Q3	11/14/2022	401,864	0.1%	1,387,940	9/30/2022
2022 Q2	8/15/2022	384,387	0.1%	1,364,092	6/30/2022
2022 Q1	5/13/2022	346,429	0.1%	1,327,466	3/31/2022
2021 Q4	2/11/2022	277,067	0.1%	1,261,688	12/31/2021
2021 Q3	11/16/2021	225,285	0.1%	1,241,985	9/30/2021
2021 Q2	8/16/2021	245,271	0.1%	1,216,439	6/30/2021
2021 Q1	5/17/2021	259,249	0.1%	1,206,425	3/31/2021
2020 Q4	2/16/2021	297,925	0.1%	1,260,577	12/31/2020
2020 Q3	11/13/2020	352,297	0.2%	1,294,638	9/30/2020
2020 Q2	8/20/2020	358,795	0.2%	1,235,900	6/30/2020
2020 Q1	5/15/2020	277,335	0.2%	1,165,514	3/31/2020
2019 Q4	2/7/2020	247,105	0.1%	1,128,589	12/31/2019
2014 Q2	7/30/2014	46,104	0.1%	486,936	6/30/2014
2014 Q1	4/29/2014	32,815	0.1%	464,013	3/31/2014
2013 Q4	2/14/2014	33,590	0.1%	452,084	12/31/2013